EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $784,000 | -13.7% | 25,250 | +14.2% | 2.30% | +10.5% |
| Q1 2022 | $908,000 | +1.5% | 22,111 | +7.4% | 2.08% | +45.6% |
| Q4 2021 | $895,000 | -34.9% | 20,591 | -25.0% | 1.43% | -14.0% |
| Q3 2021 | $1,375,000 | +15.4% | 27,460 | +45.2% | 1.67% | +19.3% |
| Q2 2021 | $1,191,000 | -38.8% | 18,915 | -9.7% | 1.40% | -34.9% |
| Q1 2021 | $1,947,000 | +437.8% | 20,957 | +357.9% | 2.14% | +310.7% |
| Q2 2020 | $362,000 | +37.1% | 4,577 | +0.2% | 0.52% | +22.2% |
| Q1 2020 | $264,000 | 0.0% | 4,570 | -6.7% | 0.43% | +81.7% |
| Q4 2019 | $264,000 | 0.0% | 4,897 | -3.0% | 0.24% | -18.7% |
| Q3 2019 | $264,000 | -14.6% | 5,050 | +7.5% | 0.29% | +105.0% |
| Q3 2018 | $309,000 | -27.3% | 4,697 | -41.8% | 0.14% | -7.2% |
| Q1 2018 | $425,000 | +30.4% | 8,066 | +15.0% | 0.15% | +36.9% |
| Q4 2017 | $326,000 | +19.4% | 7,016 | +4.1% | 0.11% | +26.1% |
| Q3 2017 | $273,000 | – | 6,741 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |